Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BL-M07D1 in Recurrent or Metastatic Gynecologic Malignancies
NCT06131450Phase 2Recruiting
- Sponsor
- Biokin Pharmaceutical
- Start
- Feb 2024
- Primary completion
- Jan 2027
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BL-M07D1 in gynecologic malignancies, sponsored by Biokin Pharmaceutical. Started Feb 2024; status: recruiting.
02
Drugs
BL-M07D1
03
Conditions
gynecologic malignancies
Beyond the preview
Go deeper on NCT06131450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06131450.